The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
Open accessAbstract
Many tumor-associated antigens are derived from nonmutated “self” proteins. T cells infiltrating tumor deposits recognize self-antigens presented by tumor cells and can be expanded in vivo with vaccination. These T cells exist in a functionally tolerant state, as they rarely result in tumor eradication. We found that tumor growth and lethality were unchanged in mice even after adoptive transfer of large numbers of T cells specific for an MHC class I–restricted epitope of the self/tumor antigen gp100. We sought to develop new strategies that would reverse the functionally tolerant state of self/tumor antigen-reactive T cells and enable the destruction of large (with products of perpendicular diameters of >50 mm2), subcutaneous, unmanipulated, poorly immunogenic B16 tumors that were established for up to 14 d before the start of treatment. We have defined three elements that are all strictly necessary to induce tumor regression in this model: (a) adoptive transfer of tumor-specific T cells; (b) T cell stimulation through antigen-specific vaccination with an altered peptide ligand, rather than the native self-peptide; and (c) coadministration of a T cell growth and activation factor. Cells, vaccination, or cyto-kine given alone or any two in combination were insufficient to induce tumor destruction. Autoimmune vitiligo was observed in mice cured of their disease. These findings illustrate that adoptive transfer of T cells and IL-2 can augment the function of a cancer vaccine. Furthermore, these data represent the first demonstration of complete cures of large, established, poorly immunogenic, unmanipulated solid tumors using T cells specific for a true self/tumor antigen and form the basis for a new approach to the treatment of patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Self-citationDranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Self-citationWherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Self-citationCharacterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off
Parijs, L. V., & Abbas, A. K. (1998) · Science · doi:10.1126/science.280.5361.243 · Cited by 965
Marchand, M., van Baren, N., Weynants, P., Brichard, V., Dr�no, B., Tessier, M.-H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s · Cited by 784
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Self-citationImmunotherapy of Tumors with Autologous Tumor-Derived Heat Shock Protein Preparations
Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K. (1997) · Science · doi:10.1126/science.278.5335.117 · Cited by 680
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., & Zinkernagel, R. M. (2001) · Nature · doi:10.1038/35082583 · Cited by 493
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Self-citationSotomayor, E. M., Borrello, I., Tubb, E., Rattis, F.-M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., & Levitsky, H. I. (1999) · Nature Medicine · doi:10.1038/10503 · Cited by 407
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396
Neonatal sunburn and melanoma in mice
Noonan, F. P., Recio, J. A., Takayama, H., Duray, P., Anver, M. R., Rush, W. L., De Fabo, E. C., & Merlino, G. (2001) · Nature · doi:10.1038/35095108 · Cited by 386
Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2982 · Cited by 381
Self-citationSpinning molecular immunology into successful immunotherapy
Pardoll, D. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri774 · Cited by 360
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., & Allen, P. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00026-1 · Cited by 358
Vitiligo in Patients with Melanoma: Normal Tissue Antigens Can Be Targets for Cancer Immunotherapy
Rosenberg, S. A., & White, D. E. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199601000-00009 · Cited by 333
Self-citationSpeiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., & Ohashi, P. S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.645 · Cited by 309
Slansky, J. E., Rattis, F. M., Boyd, L. F., Fahmy, T., Jaffee, E. M., Schneck, J. P., Margulies, D. H., & Pardoll, D. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00052-2 · Cited by 309
Preparation of Cell Cultures and Vaccinia Virus Stocks
Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B., & Carroll, M. W. (1998) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0512s13 · Cited by 282
Coupling and Uncoupling of Tumor Immunity and Autoimmunity
Bowne, W. B., Srinivasan, R., Wolchok, J. D., Hawkins, W. G., Blachere, N. E., Dyall, R., Lewis, J. J., & Houghton, A. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1717 · Cited by 239
Spiotto, M. T., Yu, P., Rowley, D. A., Nishimura, M. I., Meredith, S. C., Gajewski, T. F., Fu, Y.-X., & Schreiber, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00480-6 · Cited by 236
Wang, M., Bronte, V, Chen, P. W., Gritz, L., Panicali, D., Rosenberg, S. A., & Restifo, N. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4685 · Cited by 230
Self-citationTumor immunity and autoimmunity induced by immunization with homologous DNA.
Weber, L. W., Bowne, W. B., Wolchok, J. D., Srinivasan, R., Qin, J., Moroi, Y., Clynes, R., Song, P., Lewis, J. J., & Houghton, A. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4004 · Cited by 228
Heteroclitic Immunization Induces Tumor Immunity
Dyall, R., Bowne, W. B., Weber, L. W., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J. J., Houghton, A. N., & Nikolić-Žugić, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1553 · Cited by 200
Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
Seliger, B., Wollscheid, U., Momburg, F., Blankenstein, T. J. F., & Huber, C. (2001) · PubMed · Cited by 195
Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., & Schreiber, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.229 · Cited by 195
Immunity against cancer: lessons learned from melanoma
Houghton, A. N., Gold, J. S., & Blachere, N. E. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00195-3 · Cited by 190
Cassette vectors directing expression of T cell receptor genes in transgenic mice
Kouskoff, V., Signorelli, K., Benoist, C., & Mathis, D. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00002-r · Cited by 162
Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen
Colella, T. A., Bullock, T. N. J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., Pierce, R. A., Restifo, N. P., & Engelhard, V. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1221 · Cited by 153
Self-citationTumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance
Nguyen, L. T., Elford, A. R., Murakami, K., Garza, K. M., Schoenberger, S. P., Odermatt, B., Speiser, D. E., & Ohashi, P. S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010032 · Cited by 128
Kawakami, Y., Dang, N., Wang, X., Tupesis, J. P., Robbins, P. F., Wang, R., Wunderlich, J. R., Yannelli, J. R., & Rosenberg, S. A. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200001000-00004 · Cited by 124
Self-citationComponents of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model
Kannan, K., Sharpless, N. E., Xu, J., O’Hagan, R. C., Bosenberg, M., & Chin, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336397100 · Cited by 120
Bronte, V., Tsung, K., Rao, J. B., Chen, P. W., Wang, M., Rosenberg, S. A., & Restifo, N. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5282 · Cited by 115
Self-citationEffective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes
Melief, C. J. M., van der Burg, S. H., Toes, R. E. M., OSSENDORP, F. A., & Offringa, R. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18816.x · Cited by 110
Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response
Tham, E. L., Shrikant, P. A., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1190 · Cited by 91
Autoimmunity and the Immunotherapy of Cancer: Targeting the "Self" to Destroy the "Other"
Overwijk, W. W., & Restifo, N. P. (2000) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v20.i6.10 · Cited by 83
Self-citationKjærgaard, J., Peng, L., Cohen, P. A., Drazba, J. A., Weinberg, A. D., & Shu, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6669 · Cited by 77
Trcka, J., Moroi, Y., Clynes, R., Goldberg, S. M., Bergtold, A., Perales, M., Ma, M., Ferrone, C. R., Carroll, M. C., Ravetch, J. V., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00327-8 · Cited by 69
Localization in situ of costimulatory molecules and cytokines in B‐cell non‐Hodgkin’s lymphoma
VYTH‐DREESE, Boot, J. R., DELLEMIJN, MAJOOR, OOMEN, LAMAN, Meurs, V., de Weger, & de Jong, D. (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00550.x · Cited by 65
The future of interleukin-2: enhancing therapeutic anticancer vaccines.
Overwijk, W. W., Theoret, M. R., & Restifo, N. P. (2000) · PubMed · Cited by 63
Self-citationOverwijk, W. W., Surman, D. R., Tsung, K., et al. (1997) · Methods · doi:10.1006/meth.1997.0461 · Cited by 49
Self-citationRecombinant virus vaccination against "self" antigens using anchor-fixed immunogens.
Irvine, K. R., Parkhurst, M. R., Shulman, E., Tupesis, J. P., Custer, M. C., Touloukian, C. E., Robbins, P. F., Yafal, A. G., Greenhalgh, P., Sutmuller, R. P. M., et al. (1999) · PubMed · Cited by 40
Self-citationAging and atherosclerosis in human and nonhuman primates
Cefalu, W. T., & Wagner, J. D. (1997) · AGE · doi:10.1007/s11357-997-0002-4 · Cited by 33
Cited by
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Self-citationCancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Self-citationImmunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Self-citationAdoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
Self-citation
Metadata
- Authors
- Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., Heimann, D. M., Klebanoff, C. A., Yu, Z., Hwang, L. N., Feigenbaum, L., Kruisbeek, A. M., Rosenberg, S. A., & Restifo, N. P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 569-580
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2098772563
- Cited by
- 925
- References
- 47
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.